{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:10:30Z","timestamp":1770970230016,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.ejps.2012.02.016","type":"journal-article","created":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T23:34:02Z","timestamp":1330990442000},"page":"100-105","source":"Crossref","is-referenced-by-count":30,"title":["Impact of probe compound in MRP2 vesicular transport assays"],"prefix":"10.1016","volume":"46","author":[{"given":"Heidi","family":"Kidron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Wissel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nenad","family":"Manevski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marika","family":"H\u00e4kli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raimo A.","family":"Ketola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Finel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjo","family":"Yliperttula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri","family":"Xhaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arto","family":"Urtti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2012.02.016_b0005","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1168750","article-title":"Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding","volume":"323","author":"Aller","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejps.2012.02.016_b0010","doi-asserted-by":"crossref","first-page":"23529","DOI":"10.1074\/jbc.M303515200","article-title":"Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions","volume":"278","author":"Bodo","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2012.02.016_b0015","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1124\/jpet.103.062091","article-title":"Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3","volume":"309","author":"Chu","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2012.02.016_b0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/1087057108316702","article-title":"Characterization of 5(6)-carboxy-2\u2019,7\u2019-dichlorofluorescein transport by MRP2 and utilization of this substrate as a fluorescent surrogate for LTC4","volume":"13","author":"Heredi-Szabo","year":"2008","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.ejps.2012.02.016_b0020","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1124\/dmd.108.023895","article-title":"Multidrug resistance protein 2-mediated estradiol-17beta-d-glucuronide transport potentiation: in vitro\u2013in vivo correlation and species specificity","volume":"37","author":"Heredi-Szabo","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2012.02.016_b0030","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3109\/03602530903491741","article-title":"ABCC2\/Abcc2: a multispecific transporter with dominant excretory functions","volume":"42","author":"Jemnitz","year":"2010","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejps.2012.02.016_b0035","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2174\/138945011795378504","article-title":"ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug\u2013drug interactions","volume":"12","author":"Marquez","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejps.2012.02.016_b0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejps.2011.05.003","article-title":"Characterization of rhodamine-123, calcein and 5(6)-carboxy-2\u2019,7\u2019-dichlorofluorescein (CDCF) export via MRP2 (ABCC2) in MES-SA and A549 cells","volume":"43","author":"Munic","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2012.02.016_b0045","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1021\/jm7015683","article-title":"Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2)","volume":"51","author":"Pedersen","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2012.02.016_b0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview","volume":"55","author":"Schinkel","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2012.02.016_b0055","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/1087057110385230","article-title":"Comparison of 3 assay systems using a common probe substrate, calcein AM, for studying P-gp using a selected set of compounds","volume":"16","author":"Szeremy","year":"2011","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.ejps.2012.02.016_b0060","doi-asserted-by":"crossref","first-page":"23538","DOI":"10.1074\/jbc.M303504200","article-title":"Evidence for two interacting ligand binding sites in human multidrug resistance protein 2 (ATP binding cassette C2)","volume":"278","author":"Zelcer","year":"2003","journal-title":"J. Biol. Chem."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098712000942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098712000942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T14:51:56Z","timestamp":1543157516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098712000942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":12,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0928098712000942"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2012.02.016","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}